(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.29%) $10.87
(0.01%) $0.792
(0.02%) $92.60
4 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 9.08%
Live Chart Being Loaded With Signals
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders...
Stats | |
---|---|
Today's Volume | 187 949 |
Average Volume | 272 109 |
Market Cap | 85.28M |
EPS | $-0.240 ( 2023-11-09 ) |
Next earnings date | ( $-0.290 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.570 |
ATR14 | $0.00600 (0.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Sandercock Colin | Buy | 175 000 | Stock Option (right to buy) |
2024-03-06 | Suri Anish | Buy | 300 000 | Stock Option (right to buy) |
2024-03-06 | Millar Kerri-ann | Buy | 250 000 | Stock Option (right to buy) |
2024-03-06 | Passeri Daniel R | Buy | 400 000 | Stock Option (right to buy) |
2024-03-06 | Levisetti Matteo | Buy | 260 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
97.37 |
Last 98 transactions |
Buy: 5 498 246 | Sell: 593 660 |
Volume Correlation
Cue Biopharma Inc Correlation
10 Most Positive Correlations | |
---|---|
NLTX | 0.886 |
RPHM | 0.872 |
RNAZ | 0.843 |
SGTX | 0.843 |
ACLX | 0.842 |
ADMP | 0.842 |
NISN | 0.834 |
SDIG | 0.833 |
RMRM | 0.832 |
VCXA | 0.828 |
10 Most Negative Correlations | |
---|---|
TCBS | -0.877 |
CDW | -0.875 |
MYNZ | -0.87 |
RGP | -0.865 |
RBBN | -0.863 |
PTSI | -0.862 |
CASS | -0.858 |
HOFT | -0.858 |
LSAK | -0.846 |
FFBW | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cue Biopharma Inc Correlation - Currency/Commodity
Cue Biopharma Inc Financials
Annual | 2022 |
Revenue: | $1.25M |
Gross Profit: | $-560 828 (-45.04 %) |
EPS: | $-1.480 |
Q3 | 2023 |
Revenue: | $2.10M |
Gross Profit: | $1.24M (59.19 %) |
EPS: | $-0.240 |
Q2 | 2023 |
Revenue: | $1.38M |
Gross Profit: | $534 000 (38.64 %) |
EPS: | $-0.290 |
Q1 | 2023 |
Revenue: | $187 000 |
Gross Profit: | $-693 000 (-370.59 %) |
EPS: | $-0.300 |
Financial Reports:
No articles found.
Cue Biopharma Inc
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators